The 4th Annual Genotoxic Impurities Summit: Nitrosamines & Beyond 2024 is hosting an online meeting with subject matter experts to address challenges related to mutagenic impurities. Impurities can impact pharmaceutical efficacy, safety, and quality, necessitating thorough assessment and management. In collaboration with industry professionals, the summit aims to discuss strategies for identifying and managing genotoxic contaminants, including nitrosamines. Topics include adherence to regulatory guidelines, updates to ICH M7 and Q3D, nitrosamine impurity determination, risk assessment, analytical challenges, and elemental impurity assessment. Participants will gain insights into nitrosamine risk assessment, contamination minimization, appropriate analytical tools, and practical application of regulatory guidance. Reserve a spot for this webinar to glean new ideas and best practices for impurity management.

 [Read on uventia.com](https://www.uventia.com/event/4th-annual-genotoxic-impurities-summit-nitrosamines-beyond-2024/)

4th Annual Genotoxic Impurities Summit: Nitrosamines & Beyond 2024 is held on  4-5 December -2024. AGIM planning to hold an online meeting with subject matter experts to evaluate different points of view on how to solve the problems associated with mutagenic impurities.Impurities may have a negative effect on the efficacy, safety, and quality of pharmaceutical components and products. The successful development and manufacturing of novel medications now depend heavily on the assessment of the impurity profiles as well as the management and monitoring of those. The diligent identification of nitrosamines and other genotoxic contaminants should be established at every step of drug development in order to comply with growing regulatory requirements and prevent costly recalls. 

[Read on uventia.com](https://www.uventia.com/event/4th-annual-genotoxic-impurities-summit-nitrosamines-beyond-2024/)

The 13th Tumour Models London Summit  is held on 04 - 05 December 2024 in London, UK.With 5% of cancer drugs going into the clinic, it is critical that oncology scientists invest in more translational and predictive models to de-risk the validation of novel targets, predict therapeutic response, and support biomarker discovery, particularly with such a high price tag for clinical failure.The 13th Tumour Models London Summit stands as the only industry-led meeting uniting pharma, biotech, and preclinical CROs from Europe to network and discuss new trends and innovations in tumour models. 

 [Read on tumour-models.com](https://tumour-models.com/take-part/register/)

Rapid advancements in science are producing dividends for health: The first gene therapies have been approved by regulators, new cancer therapies are yielding promising results without harmful side effects, and GLP-1s are now able to treat a wide swathe of chronic diseases. The AI revolution is unleashing new ways to discover drugs, personalize medicine and even manage a doctor’s paperwork. But healthcare innovation goes beyond scientific and technical advancements.Join at the 13th annual Forbes Healthcare Summit, where they will convene top leaders across the $4 trillion healthcare industry and gain insight into the entrepreneurship, investment and new thinking that’s driving the future of healthcare.

Read on forbes.com

Personalized Cancer Vaccine Summit is held on 03-05 December 2024 in Boston, MA.The Personalized Cancer Vaccine Summit (formerly known as the mRNA Cancer Vaccine Summit) returns to Boston for the third year bringing together the top industry players developing individualized approaches across several modalities including mRNA, DNA, peptides, viral, dendritic cell and more to share how they are conquering common challenges, developing novel bioinformatic strategies, and achieving clinical efficacy.With recent advancements into Phase II and III trials for personalized cancer vaccines along with 437 other candidates in development, the biopharma industry is at a critical point to demonstrate safe and efficacious results that will offer a real hope for every patient with a cure for cancer. 

[Read on personalized-cancer-vaccines.com](https://personalized-cancer-vaccines.com/take-part/register/)

International Conference on Recent Advances in Medical, Medicine and Health Sciences(ICRAMMHS)  will be held on 03rd Dec-04th Dec 2024 at  Houston,United States of America.  ICRAMMHS  is to bring together innovative academics and industrial experts in the field of Business Management and Social Innovation to a common forum. All the registered papers will be published by the World Research Library and will be submitted for review for indexing by Google Scholar etc.This Conference is sponsored by  many International institutes. The conference would offer a large number of invited lectures from renowned speakers all over the country. The Best paper awards will be given for the papers judged to make the most significant contribution to the conference.

Read on wrfer.org

The Annual Innovations in Wound Healing Conference, scheduled from December 3rd to 6th, 2024, invites attendees to explore new approaches to tissue repair across the human body. Led by experienced educators, scientists, and clinicians, this unique gathering focuses on the science and implementation of tissue repair advancements. With a vision to foster collaboration and exchange of cutting-edge ideas, the program spans molecular biology to clinical development. Attendees will benefit from formal presentations, informal discussions, and poster sessions, facilitating networking and knowledge sharing. This conference provides a valuable platform for addressing critical medical needs and advancing the understanding and treatment of wound healing.

 [Read on whinnovations](https://whinnovations.com/)

The Cell and Gene Therapy Medical Affairs Summit is sheduled on 03-05 December 2024 in Boston, MA,Delivering Impactful Education to Transform Patient Outcomes.Introducing the Cell and Gene Therapy Medical Affairs Summit, the premier event highlighting the essential role of medical affairs in delivering therapies to patients. Explore how traditional approaches are being revolutionized to tackle the unique challenges of cell and gene therapy drug development. Here, the fusion of scientific and clinical expertise with strategic commercial vision creates opportunities for transformative breakthroughs! 

[Read on cell-gene-therapy-medical-affairs.com](https://cell-gene-therapy-medical-affairs.com/take-part/register/)

The 6th Targeted Radiopharmaceuticals Summit Europe is held on 03-05 December  2024 in Amsterdam,Europe**.**This year has been the year for radiopharmaceuticals, with market projections estimating to grow to $39 billion by 2032. More patients are being treated by Pluvicto and Lutathera than ever before, companies advancing their pipelines across a range of targeting moieties, radioisotopes and novel targets including DLL3 and NTSR1- and that's not to mention the flood of billion-dollar acquisitions and investments from Novartis, AstraZeneca, Eli Lilly and BMS strengthening the field! The 6th Targeted Radiopharmaceuticals Summit Europe is the longest standing industry focused meeting delivering an end-to-end overview of this highly competitive and dynamic landscape. 

[Read on targeted-radiopharma.com](https://targeted-radiopharma.com/take-part/register/)

6th CNS Drug Delivery Summit is sheduled on 03-05 December 2024 in Boston, MA.CNS drug development is facing a new era, thanks to huge strides in neuroscience innovation, including advances in blood-brain barrier transport, CSF administration, and device-mediated delivery, to solve the field's most pressing challenge: access to the brain.Riding the wave of drug delivery innovation, the industry's definitive 6th CNS Drug Delivery Summit returns to showcase breakthrough progress in receptor-mediated transcytosis, CSF dose escalation, quantifying brain distribution, BBB modeling, CED and FUS technology, emerging modalities including LNPs, and more.

 [Read on cns-drug-delivery.com](https://cns-drug-delivery.com/take-part/register/)